Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.123 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.154EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.137EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.446EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.76 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.3 (Theta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used